|
Nair, Smita K; Morse, Michael; Boczkowski, David et al. (2002) Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells. Ann Surg 235:540-9
|
|
Morse, Michael A; Nair, Smita K; Boczkowski, David et al. (2002) The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer. Int J Gastrointest Cancer 32:1-6
|
|
Morse, Michael A; Lyerly, H Kim (2002) DNA and RNA modified dendritic cell vaccines. World J Surg 26:819-25
|
|
Lyerly, H K; Morse, M A; Clay, T M (2001) Surrogate markers of effective anti-tumor immunity. Ann Surg Oncol 8:190-1
|
|
Hobeika, A C; Clay, T M; Mosca, P J et al. (2001) Quantitating therapeutically relevant T-cell responses to cancer vaccines. Crit Rev Immunol 21:287-97
|
|
Morse, M A; Clay, T M; Hobeika, A C et al. (2001) Surrogate markers of response to cancer immunotherapy. Expert Opin Biol Ther 1:153-8
|
|
Nair, S K; Hull, S; Coleman, D et al. (1999) Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA. Int J Cancer 82:121-4
|
|
Morse, M A; Coleman, R E; Akabani, G et al. (1999) Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res 59:56-8
|
|
Morse, M A; Vredenburgh, J J; Lyerly, H K (1999) A comparative study of the generation of dendritic cells from mobilized peripheral blood progenitor cells of patients undergoing high-dose chemotherapy. J Hematother Stem Cell Res 8:577-84
|
|
Morse, M A; Deng, Y; Coleman, D et al. (1999) A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. Clin Cancer Res 5:1331-8
|
